AKT1 and breast cancer: The most three frequent mutations E542K, E545K and H1047R are all responsible for enzymatic activation of the PI3Kα; however, in mice models, PIK3CA H1047R has shown to be a stronger inducer of breast cancer, in terms of both latency and frequency, maybe explained by the higher activation of the downstream AKT signaling [21].